|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12P 21/02 | (2006.01) |
| C12P 21/02 | (2013.01) | ||
| C12N 15/67 | (2006.01) | ||
| C12P 21/00 | (2006.01) |
| (11) | Number of the document | 3665286 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18752135.6 |
| Date of filing the European patent application | 2018-08-06 | |
| (97) | Date of publication of the European application | 2020-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/071229 |
| Date | 2018-08-06 |
| (87) | Number | WO 2019/030155 |
| Date | 2019-02-14 |
| (30) | Number | Date | Country code |
| 201715631510 | 2017-08-11 | US |
| (72) |
KVAM, Erik, Leeming , US
NELSON, John, Richard , US
GAO, Wei , US
|
| (73) |
Global Life Sciences Solutions Operations UK Ltd ,
19 Jessops Riverside
800 Brightside Lane, Sheffield
S9 2RX,
GB
|
| (54) | CELL-FREE PROTEIN EXPRESSION USING DOUBLE-STRANDED CONCATAMERIC DNA |
| CELL-FREE PROTEIN EXPRESSION USING DOUBLE-STRANDED CONCATAMERIC DNA |